C07D 213/36
Radicals substituted by singly-bound nitrogen atoms
Official title: Radicals substituted by singly-bound nitrogen atoms (nitro radicals C07D213/26)
C07D213/36 (Radicals substituted by singly-bound nitrogen atoms) appears on 2,737 US grants and 2,524 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,737
- Published applications
- 2,524
- Assignees
- 1,201
- Inventors
- 8,424
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 25 | 0 |
| 1977 | 32 | 0 |
| 1978 | 35 | 0 |
| 1979 | 21 | 0 |
| 1980 | 24 | 0 |
| 1981 | 21 | 0 |
| 1982 | 22 | 0 |
| 1983 | 26 | 0 |
| 1984 | 24 | 0 |
| 1985 | 29 | 0 |
| 1986 | 23 | 0 |
| 1987 | 27 | 0 |
| 1988 | 31 | 0 |
| 1989 | 28 | 0 |
| 1990 | 37 | 0 |
| 1991 | 42 | 0 |
| 1992 | 34 | 0 |
| 1993 | 45 | 0 |
| 1994 | 45 | 0 |
| 1995 | 40 | 0 |
| 1996 | 64 | 0 |
| 1997 | 63 | 0 |
| 1998 | 71 | 0 |
| 1999 | 48 | 0 |
| 2000 | 52 | 0 |
| 2001 | 68 | 9 |
| 2002 | 75 | 100 |
| 2003 | 85 | 131 |
| 2004 | 82 | 170 |
| 2005 | 66 | 135 |
| 2006 | 75 | 129 |
| 2007 | 81 | 104 |
| 2008 | 68 | 128 |
| 2009 | 82 | 119 |
| 2010 | 76 | 125 |
| 2011 | 92 | 104 |
| 2012 | 90 | 101 |
| 2013 | 80 | 100 |
| 2014 | 91 | 151 |
| 2015 | 90 | 106 |
| 2016 | 89 | 102 |
| 2017 | 85 | 112 |
| 2018 | 74 | 83 |
| 2019 | 78 | 73 |
| 2020 | 58 | 86 |
| 2021 | 62 | 72 |
| 2022 | 53 | 70 |
| 2023 | 33 | 68 |
| 2024 | 37 | 61 |
| 2025 | 34 | 46 |
| 2026 | 24 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Anti-inflammatory carboxamide derivatives21 Jul 2026US 12,686,657 B2Biomedcode Hellas SA
- Light emitting device and amine compound for the same9 Jun 2026US 12,649,724 B2Samsung Display Co., Ltd.
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Light emitting device and amine compound for the same10 Sep 2026US 2026/0265211 A1Samsung Display Co., Ltd.
Most cited
By later US patents
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Formulations and methods for treatment of mucosal associated conditions with an immune response modifier193US 6,486,168 B13M Innovative Properties Company · 2002
- Dimeric and trimeric nucleic acid dyes, and associated systems and methods164US 7,776,567 B2AlleLogic Biosciences Corporation · 2010
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997